For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...
A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
Hosted on MSN1d
What is Ozempic and How Does it Work? Everything You Need to Know About This MedicationOzempic has become a popular treatment for type 2 diabetes and weight loss. Discover how it works, its benefits, and ...
News Medical on MSN1d
Do GLP-1 receptor agonists increase the risk of suicide in patients?A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...
Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...
The following is a summary of “Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative ...
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...
These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback